Corel Medical Series: Cancer/Corel Medical Series: Cancer.iso/mac/Program/Indexdat/indexc.S

Text File | 1997-01-27 | 5KB | 3 lines

S-phase testing,p02.20,Safety equipment home care,p26.4,Salivart,p18.16,Salivary gland tumor,c14a.1;c14a.7;c14b.14,Salivary glands diagram,c14b.14,Sarcoid,c41.2,Sarcoma,6,Sarcoma botryoides,c46.1,Scarring post-operative,p05.19,Schwannoma,c38.2,Scirrhous carcinoma,c39.2,Screening genetic,p01.5;p36.7,Screening tests,1,Second opinion,p04.15;p05.19,Segmental resection,c06.19;c06.35,Seizures,c05.5,Self-esteem,2,Self-examination,2,Seminoma testis cancer,c40.1,Senna,p17.24,Senokot,p17.24,Sepsis,p20.3,Serous epithelium carcinoma,c29.1,Seven Early Warning Signals (CAUTION),p02.3,Sexual practices,5,Sexuality,5,Side effects,11,Silent period,p01.3,Silicone implants,REC.6,Sitz baths,p26.5,Skeletal lesions,c07.15,Skin diagram,c25.11,Skin cancer,11,Skin care,p26.9,Sleeping pills,p17.23;p23.8,Small bowel carcinoid,c08.11,Small cell carcinoma,c02.2;c31.1,Small intestine cancer,11,Smell changes,p18.3,Smoking,9,Smoldering multiple myeloma,c28.2,Sodium,p17.24,Soft tissue and bone sarcoma,2,Solitary myeloma of bone,c28.2,Solitary plasmacytoma,c28.3,Somatic pain,p19.3,Somatostatin,2,Somatostatin-producing tumor,c15.15,Sore mouth,3,Sore throat,p20.5,Speech therapist,p03.6,Spermatocytic seminoma testis cancer,c40.1,Spinal cord tumor,c05.24,Spiritual care,p27.7,Spirituality,p29.2;p29.7,Squamous cell carcinoma,14,Stabilization after chemotherapy,p07.5,Staging,4,Stein-Leventhal syndrome,c44.3,Stem cells,p07.20,Stereotactic surgery,p06.9;c05.23;c27.8,Sterility,p12.10;c40.26,Steroids,p19.8;c19.3;c27.7,Stomach diagram,c13.8,Stomach cancer,11,Stool softeners,p17.23,Stool tests,p02.9;p20.10,Streptozocin,5,Stress,4,Stress management,p25.6,Stromal tumor ovary,c29.2,Strontium,p06.11,Sucralfate,p18.15;p18.16,Sunlight,2,Sunscreens,c37.7,Superficial spreading adenocarcinoma,c39.2,Superficial tumor,c04.4,Support groups,4,Suppressor genes,p01.5;p36.5;p36.10,Suramin,p35.11;c35.31,Surgeon,2,Surgery,10,Surveillance Epidemiology and End Results (SEER) Program,p33.3,Survivors guilt,p29.8,Survivorship,p31.5,Sustacal,p17.19;p18.8;p18.12,Sweat gland carcinoma breast,c06.3,Swelling,p08.17,Symptoms,5,Syngeneic bone marrow transplantation,p12.6,Syphilis,p14.3,Syrinx,c05.25,Systemic radiation therapy,p06.11,
defined,p01.12,endometrial stromal,c45.1,locations,11,osteogenic,c10a.2;c10a.5,treatment,p12.22,unknown primary site,c07.1,table,CHR.p34.19,restoring,p22.1,retaining,p16.12,breast,p34.17;c06.8,testis,p34.17;c40.7,anal cancer,c02.3,cervical cancer,c09.3,Kaposi's sarcoma,c16.4,risk factor,p01.9;p34.8,vulvar cancer,c47.3,after treatment,p23.5,and ostomy,p21.11;p23.14,phases,p23.3,problems,p23.5,resuming activity,p23.15;p30.8,biological therapy,p08.17,body image,p16.13,bone marrow transplantation,p12.10,chemotherapy,p07.25,coping with,p17.1,hyperthermia,p10.6,hyperthermic perfusion therapy,p11.7,of drugs,p19.9;p26.13,radiation therapy,p06.15,and stopping therapy,p07.19,and treatment options,p04.13,causes,c37.4,diagnosis,c37.11,follow-up,c37.21,prevention,c37.7,questions to ask,c37.22,risk factors,c37.5,screening,c37.9,spread,c37.3,symptoms,c37.10,treatment,c37.13,types,c37.1,causes,c38.3,diagnosis,c38.7,questions to ask ,c38.17,recurrent,c38.16,risk factors,c38.4,screening,c38.5,spread,c38.3,staging ,c38.9,symptoms,c38.6,treatment,c38.10,types,c38.2,anal cancer,c02.3,bladder cancer,c04.4,cervical cancer,c09.6,esophageal cancer,c12.3,head and neck cancers,c14a.5,lung cancer,c20.3;c21.3,pancreas,c31.2;c31.3,risk factor,p01.7;p34.12;p34.15,and surgery,p05.12,adult,12,child,6,for islet cell carcinoma,c15.15,for pitiutary cancer,c34.6,coping with,p17.16,from chemotherapy,p07.26;p17.18;p19.5,from radiation therapy,p06.18;p17.16;p18.14,anus,c02.1,bile duct,c03.1,bladder,c04.1,breast,c06.2,cervix,c09.1;c09.12,esophagus,c12.2,gall bladder,c13.1,lung,c20.2,neck,c14a.2;c14a.7;c14b.41,penis,c33.1,skin,c37.1,unknown primary source,c14a.2,vagina,C46.1,vulva,C47.2,after perfusion therapy,p11.3,defined,p01.17,surgical diagnosis,p05.4,and treatment options,p01.19;p04.9,causes,c39.2,diagnosis,c39.8,questions to ask,c39.29,recurrence,c39.27,risk factors,c39.4,screening,c39.6,spread,c39.2,staging,c39.10,symptoms,c39.7,treatment,c39.11,types,c39.2,for gastrointestinal tract cancer,c08.14,for islet cell carcinoma,c08.8,for pancreatic cancer,c31.11,for small intestine cancer,c38.11,side effects,chr.p17.13,about sexuality,p23.7;p23.23,negative,p25.4,positive,p25.3,risk factor,p01.8,avoiding,p34.13,promotes cancer,p01.7;p34.7;c25.4;c37.5,cancer,p30.7,ostomy,p21.14,sexuality,p23.2;p23.15,value of,p15.12;p16.16,choosing,p05.19,role,p03.4,anesthetics,p05.15,diagnostic,p05.4,in combination therapy,p04.6;p05.7;p05.8,pain,p05.15,preparing for,p05.12,prophylactic,p05.3,purposes,p04.12;p05.3,risks,p05.17,side effects,p19.3,treatment option,p04.4,early detection,p34.17,nursing management,p15.12,radiotherapeutic relief,p06.1,Seven Early Warning Signals,p02.3,surgical relief,p05.3,
anus,c02.1,bile duct,c03.1,breast,c06.3,gall bladder,c13.1,liver,c19.1,penis,c33.1,small intestine,c38.2,thyroid,c42.2,uterus,c45.1,vagina,c46.1,vulva,c47.2,causes,c36.3,diagnosis,c36.8,follow-up,c36.20,questions to ask,c36.22,recurrence,c36.21,risk factors,c36.4,spread,c36.2,staging ,c36.9,symptoms,c36.7,treatment,c36.10,types,c36.2,types (table),chr.c36.2 ,Ewing's sarcoma,c10d.1;c10d.10,osteogenic sarcoma,c10d.1;c10d.7,questions to ask,c10d.13,recurrence,c10d.12;c10d.9,rhabdomyosarcoma,c10d.3,types,c10d.1;chr.c10d.6,